IsoPlexis Garners $2,350,000 New Financing

  • Feed Type
  • Date
    6/1/2015
  • Company Name
    IsoPlexis
  • Mailing Address
    55 Whitney Ave. 2nd Floor New Haven, CT 06520 USA
  • Company Description
    Our proprietary single-cell multiplexing micro-immunoassay and software enable new therapeutic and diagnostic discovery opportunities. Single cell analysis facilitates determination of cellular subsets among heterogeneous cancer and immune cell populations.
  • Website
    http://www.isoplexis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,350,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor